Jasem Al–Hashel

1.3k total citations
67 papers, 872 citations indexed

About

Jasem Al–Hashel is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Jasem Al–Hashel has authored 67 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pathology and Forensic Medicine, 19 papers in Neurology and 13 papers in Rheumatology. Recurrent topics in Jasem Al–Hashel's work include Multiple Sclerosis Research Studies (39 papers), Peripheral Neuropathies and Disorders (15 papers) and Polyomavirus and related diseases (10 papers). Jasem Al–Hashel is often cited by papers focused on Multiple Sclerosis Research Studies (39 papers), Peripheral Neuropathies and Disorders (15 papers) and Polyomavirus and related diseases (10 papers). Jasem Al–Hashel collaborates with scholars based in Kuwait, Egypt and United Kingdom. Jasem Al–Hashel's co-authors include Raed Alroughani, Samar Farouk Ahmed, Raed Behbehani, Saeed Akhtar, Ismail Ibrahim Ismail, Aaron D. Besterman, Christina Wolfson, A Thussu, Peter J. Goadsby and Walaa A. Kamel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Jasem Al–Hashel

64 papers receiving 860 citations

Peers

Jasem Al–Hashel
Gabriel Pardo United States
Liliana Patrucco Argentina
Jihad Inshasi United Arab Emirates
Pål Berg‐Hansen Norway
Élisabeth Maillart France
Norman J. Kachuck United States
Giovanni Bosco Zimatore Italy
Christina Caon United States
Ryan Ramanujam Sweden
David Magalashvili Israel
Gabriel Pardo United States
Jasem Al–Hashel
Citations per year, relative to Jasem Al–Hashel Jasem Al–Hashel (= 1×) peers Gabriel Pardo

Countries citing papers authored by Jasem Al–Hashel

Since Specialization
Citations

This map shows the geographic impact of Jasem Al–Hashel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasem Al–Hashel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasem Al–Hashel more than expected).

Fields of papers citing papers by Jasem Al–Hashel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasem Al–Hashel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasem Al–Hashel. The network helps show where Jasem Al–Hashel may publish in the future.

Co-authorship network of co-authors of Jasem Al–Hashel

This figure shows the co-authorship network connecting the top 25 collaborators of Jasem Al–Hashel. A scholar is included among the top collaborators of Jasem Al–Hashel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasem Al–Hashel. Jasem Al–Hashel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al–Hashel, Jasem, et al.. (2025). Efficacy of onabotulinumtoxinA treatment in episodic migraine. Frontiers in Neurology. 15. 1459767–1459767.
2.
Al–Hashel, Jasem, et al.. (2025). Effectiveness of 6-week dosing of Natalizumab versus continued 4-week treatment for Multiple Sclerosis: An observational registry-based study. Multiple Sclerosis and Related Disorders. 94. 106297–106297. 1 indexed citations
3.
4.
Al–Hashel, Jasem, et al.. (2024). Unmet Needs of Patients Living with Migraine in the Gulf Cooperation Council (GCC) Countries. Pain and Therapy. 13(2). 201–210. 1 indexed citations
5.
Al–Hashel, Jasem, et al.. (2023). Ocrelizumab and Cladribine Had Similar EDSS Stability in Patients with Highly Active Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 80. 105330–105330. 1 indexed citations
6.
Alroughani, Raed, et al.. (2023). A real-life study of alemtuzumab in persons with multiple sclerosis: Kuwait's experience. Multiple Sclerosis and Related Disorders. 74. 104712–104712. 2 indexed citations
7.
Ismail, Ismail Ibrahim, et al.. (2022). Tacrolimus-Induced Leukoencephalopathy in a Renal Transplantation Patient. SHILAP Revista de lepidopterología. 5(2). 103–106. 1 indexed citations
8.
Alroughani, Raed, et al.. (2022). Prevalence, severity, outcomes, and risk factors of COVID-19 in multiple sclerosis: An observational study in the Middle East. Journal of Clinical Neuroscience. 99. 311–316. 4 indexed citations
9.
10.
Ismail, Ismail Ibrahim, et al.. (2020). Effect of Ramadan fasting on Myasthenia Gravis (2069). Neurology. 94(15_supplement). 1 indexed citations
11.
Ismail, Ismail Ibrahim, et al.. (2020). Radiological characteristics of neuromyelitis optica spectrum disorder in Kuwait. Clinical Neurology and Neurosurgery. 196. 106047–106047. 1 indexed citations
12.
Alroughani, Raed, Saeed Akhtar, Maya Zeineddine, et al.. (2019). Risk of relapses during pregnancy among multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 34. 9–13. 19 indexed citations
13.
Alroughani, Raed, et al.. (2019). The prevalence of multiple sclerosis continues to increase in Kuwait. Multiple Sclerosis and Related Disorders. 32. 74–76. 23 indexed citations
14.
Alroughani, Raed, Samar Farouk Ahmed, Raed Behbehani, & Jasem Al–Hashel. (2017). The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective Study. Pediatric Neurology. 70. 56–60. 23 indexed citations
15.
Sauerbier, Anna, Onanong Jitkritsadakul, Nataliya Titova, et al.. (2017). Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations. Neuroepidemiology. 49(1-2). 1–17. 27 indexed citations
16.
Akhtar, Saeed, Raed Alroughani, Samar Farouk Ahmed, & Jasem Al–Hashel. (2016). Retrospective Cohort Study of Gender Differential in Risk of Multiple Sclerosis in Kuwait. Neuroepidemiology. 46(3). 203–208. 7 indexed citations
17.
Behbehani, Raed, Samar Farouk Ahmed, Jasem Al–Hashel, Rossen T. Rоusseff, & Raed Alroughani. (2016). Sensitivity of visual evoked potentials and spectral domain optical coherence tomography in early relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 12. 15–19. 13 indexed citations
18.
Alroughani, Raed, Samar Farouk Ahmed, Raed Behbehani, & Jasem Al–Hashel. (2014). Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait. Clinical Neurology and Neurosurgery. 119. 17–20. 9 indexed citations
19.
Alroughani, Raed, et al.. (2013). Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. Multiple Sclerosis Journal. 20(5). 543–547. 94 indexed citations
20.
Al–Hashel, Jasem, Samar Farouk Ahmed, Raed Alroughani, & Peter J. Goadsby. (2013). Migraine misdiagnosis as a sinusitis, a delay that can last for many years. The Journal of Headache and Pain. 14(1). 97–97. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel Pardo Breakdown of academic impact, for papers by Liliana Patrucco Breakdown of academic impact, for papers by Jihad Inshasi Breakdown of academic impact, for papers by Pål Berg‐Hansen Breakdown of academic impact, for papers by Élisabeth Maillart Breakdown of academic impact, for papers by Norman J. Kachuck Breakdown of academic impact, for papers by Giovanni Bosco Zimatore Breakdown of academic impact, for papers by Christina Caon Breakdown of academic impact, for papers by Ryan Ramanujam Breakdown of academic impact, for papers by David Magalashvili
Rankless by CCL
2026